BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 193 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2018. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $414,953 | -0.8% | 3,850 | -12.7% | 0.17% | +3.0% |
Q1 2024 | $418,333 | +83.6% | 4,410 | +78.5% | 0.16% | +67.3% |
Q4 2023 | $227,833 | -97.3% | 2,470 | -98.5% | 0.10% | -94.0% |
Q3 2023 | $8,330,996 | -3.7% | 165,890 | +21.2% | 1.62% | +12.5% |
Q2 2023 | $8,648,098 | +57.7% | 136,837 | +12.3% | 1.44% | +36.8% |
Q1 2023 | $5,484,281 | +8.0% | 121,900 | +5.2% | 1.05% | +7.2% |
Q4 2022 | $5,077,579 | -29.9% | 115,900 | +5.5% | 0.98% | -31.1% |
Q3 2022 | $7,241,000 | +75.0% | 109,900 | +34.2% | 1.43% | +71.1% |
Q2 2022 | $4,137,000 | -20.9% | 81,900 | 0.0% | 0.83% | -10.2% |
Q1 2022 | $5,232,000 | -25.8% | 81,900 | +24.5% | 0.93% | -12.4% |
Q4 2021 | $7,048,000 | -54.0% | 65,800 | -51.8% | 1.06% | -1.7% |
Q4 2020 | $15,308,000 | -44.0% | 136,500 | -53.7% | 1.08% | -54.1% |
Q3 2020 | $27,322,000 | +20.5% | 294,733 | +1.4% | 2.35% | +12.9% |
Q2 2020 | $22,665,000 | +528.7% | 290,583 | +545.7% | 2.08% | +286.8% |
Q4 2019 | $3,605,000 | +248.0% | 45,000 | +309.7% | 0.54% | +333.9% |
Q2 2019 | $1,036,000 | +209.3% | 10,984 | +162.5% | 0.12% | +210.0% |
Q1 2019 | $335,000 | +48.2% | 4,184 | 0.0% | 0.04% | +29.0% |
Q4 2018 | $226,000 | -30.9% | 4,184 | 0.0% | 0.03% | -11.4% |
Q3 2018 | $327,000 | – | 4,184 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |